Friday, November 20, 2026
RSS

Pharmaceutical

PMV Pharmaceuticals’ Updated Rezatapopt Data Puts Precision Oncology Back in Focus

PMV Pharmaceuticals’ updated PYNNACLE Phase 2 data gives investors a closer look at rezatapopt and its TP53 Y220C precision-oncology strategy.

November 20, 2026
Pharmaceutical
Pharmaceutical
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.


Pharmaceutical

Savara Shares Slip After FDA Delays Autoimmune PAP Decision

Savara’s missed FDA target date leaves investors facing a longer wait for clarity on its autoimmune …

Nov 20, 2026
Pharmaceutical

Revolution Medicines Rallies on Clinical Data as Biotech Decouples From Weak Market

Revolution Medicines showed premarket relative strength as clinical data offset a 1.0% S&P 500 decli…

Nov 20, 2026
Pharmaceutical

Capricor Therapeutics Defies Market Selloff as Traders Position for FDA Catalyst

CAPR rallied in premarket trading as the Nasdaq and S&P 500 declined, putting the biotech’s FDA cata…

Nov 20, 2026
Pharmaceutical

Alnylam’s $25 Million Regeneron Milestone Puts Its RNAi Model in Focus

Alnylam’s $25 million Livsayis milestone highlights the commercial value of its RNAi platform and pa…

Nov 19, 2026
Pharmaceutical

Black Diamond Gains as FDA Maps Accelerated-Approval Path for Silevertinib

FDA guidance on accelerated approval and a broad EGFR mutation definition may reduce uncertainty aro…

Nov 19, 2026
Pharmaceutical

J&J Seeks FDA Approval to Expand CAPLYTA Into Bipolar Mania

J&J’s CAPLYTA filing could create a fifth potential indication, broadening its psychiatric franchise…

Nov 19, 2026
Pharmaceutical

ADC Therapeutics Pitches Zynlonta Expansion as a Commercial Growth Driver

ADC Therapeutics is emphasizing Zynlonta’s market opportunity and broader commercial availability as…

Nov 19, 2026
Pharmaceutical

Merck Maps Out Its Post-Keytruda Growth Strategy With Nine New Medicines

Merck is positioning nine newer medicines and vaccines, including intismeran, as part of its strateg…

Nov 19, 2026
Pharmaceutical

Regeneron Buy Rating Reaffirmed After Fresh FDA Approval

Truist reiterated its Buy rating on $REGN after a new FDA approval, giving traders a concrete cataly…

Nov 19, 2026